Some hugely successful entrepreneurs enjoy the spotlight, appearing regularly on television and staying in the public eye. Others tend to stay behind the scenes for the most part, so that their names don’t become well-known to the general public. Such is the case with Jim Plante, founder of Thynk Capital, Klotho Therapeutics and several other companies. All are connected in some way with the advancement of biotechnology for medical purposes.
Thynk Capital is an investment firm focusing on technology and life science companies that seek ways to extend a healthy lifespan. One particular focus is on preventing or curing diseases generally associated with aging, although some younger people develop those diseases as well. Examples include kidney disease, cancer and diabetes.
Klotho Therapeutics, in contrast, concentrates on treatment development for kidney disease and other major health problems. This company boasts an impressive medical advisory board with achievements in the battle against kidney disease and the role of the Klotho protein in treatment. For example, the scientist who discovered this protein, which is also classified as a gene, is on the board. A medical doctor who is a global leading expert in managing acute kidney disease in intensive care also has a board seat.
Foundation for Kidney Transplant Research
Knowing that Mr. Plante also is the founder of the Foundation for Kidney Transplant Research gives one the insight that this entrepreneur has a strong interest in curing kidney disease. He makes no secret of the fact that polycystic kidney disease runs in his family and that he has a genetic risk factor for it. His interest in genetics led him to found the company Pathway Genomics, which offers genetic testing to consumers.
Affordable Personalized Medicine
One of Mr. Plante’s goals is to make personalized medicine available to everyone and also to make it affordable. That may seem like a lofty dream in today’s world of very expensive medical treatments and healthcare, at least in the United States. An ongoing outcry about the difficulties so many U.S. residents have in paying for medical care makes it clear that dramatic changes must be made.